Pharma Looks to Inflammasome Inhibitors as All-Around Therapies
Pharma Looks to Inflammasome Inhibitors as All-Around Therapies
Many major biopharmaceutical companies are developing or acquiring drugs that target the NLRP3 inflammasome, a large intracellular complex that researchers say can spark inflammation and stoke diseases of lifestyle and aging.
Pharma Looks to Inflammasome Inhibitors as All-Around Therapies
Pharma Looks to Inflammasome Inhibitors as All-Around Therapies

Many major biopharmaceutical companies are developing or acquiring drugs that target the NLRP3 inflammasome, a large intracellular complex that researchers say can spark inflammation and stoke diseases of lifestyle and aging.

Many major biopharmaceutical companies are developing or acquiring drugs that target the NLRP3 inflammasome, a large intracellular complex that researchers say can spark inflammation and stoke diseases of lifestyle and aging.

inflammasomes
Could Curbing Runaway Immune Responses Treat COVID-19?
Could Curbing Runaway Immune Responses Treat COVID-19?
Shawna Williams | Apr 21, 2020
Drugs targeting patients’ immune systems, rather than the virus itself, could be key to recovery from severe cases of the disease, some researchers suggest.
Image of the Day: Dial M for Murder
Image of the Day: Dial M for Murder
The Scientist Staff | Aug 16, 2017
M proteins from Streptococcus bacteria selectively kill mouse macrophages and human macrophage-like cells by prompting cell death.
Protein Clumps Spread Inflammation
Protein Clumps Spread Inflammation
Kate Yandell | Jun 22, 2014
ASC specks—protein aggregations that drive inflammation—are released from dying immune cells, expanding the reach of a defense response.
Top 7 in Microbiology
Edyta Zielinska | Sep 26, 2011
A snapshot of the most highly ranked articles in microbiology and related areas, from Faculty of 1000